MENU

Carolyn Fang Elected Fellow to the Society of Behavioral Medicine

March 6, 2020

“I am honored and thrilled to be elected as a fellow, and I look forward to continuing my work at the intersection of behavioral medicine and cancer research,” said Dr. Fang.

PHILADELPHIA (March 6, 2020) – Carolyn Fang, PhD, a researcher at Fox Chase Cancer Center, has been elected as a fellow to the Society of Behavioral Medicine, a multidisciplinary organization of behavioral and biomedical researchers and clinicians.

“I am honored and thrilled to be elected as a fellow, and I look forward to continuing my work at the intersection of behavioral medicine and cancer research,” said Fang, a professor and co-leader of the Cancer Prevention and Control program at Fox Chase.

The Society of Behavioral Medicine is a nonprofit organization that brings together multiple disciplines such as nursing, psychology, medicine, and public health to provide new perspectives and progress on human behavior, health, and illness. It is a key forum for more than 2,400 professionals to study the interactions and relationships between behavioral, physiological, and biochemical states, and morbidity and mortality. 

Fellow status is given to full members of the society for outstanding contributions to the advancement of the science and practice of behavioral medicine. According to the society’s bylaws, “Among the considerations for this distinction are academic, professional, clinical, legislative, or other meritorious accomplishments.”

Fang received her undergraduate degree in psychology from Colgate University in New York in 1991. She then went on to the University of California, Los Angeles, where she earned her master’s degree and doctorate in psychology. She has been part of Fox Chase Cancer Center since beginning her postdoctoral fellowship there.

Much of Fang’s research focuses on understanding how behavioral, biological, and psychosocial factors may contribute to increased risk for cancer or other chronic diseases. Some of her work is focused specifically on underserved Asian American populations.

Fang is a member of the Translational Research Disease Groups for esophagus, pancreas, and liver cancer; head and neck cancer; and ovarian and gynecological cancer at Fox Chase.

Newly elected fellows will be honored at the Society of Behavioral Health’s 2020 Annual Meeting & Scientific Sessions, being held April 1-4 in San Francisco.

      

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase